Giuseppe Viglietto

Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer

N. Amodio, E. M. De Francesco, T. Soda, 2023, Journal of Translational Medicine.

The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection

I. Aversa, E. Trecarichi, C. Veneziano, 2024, Journal of translational medicine.

Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study

G. Viglietto, G. Cuda, A. Quattrone, 2022, BMC Infectious Diseases.

T‐cell immunity against Severe Acute Respiratory Syndrome Coronavirus 2 proteins in patients with type 1 diabetes

A. Gnasso, I. Aversa, C. Irace, 2024, Diabetes/metabolism research and reviews.

GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma

A. Neri, G. Passarino, D. Bellizzi, 2023, Cells.

Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity

F. Grande, F. Conforti, E. Martino, 2024, Journal of translational medicine.

Persistence of SARS‐CoV‐2 infection and viral intra‐ and inter‐host evolution in COVID‐19 hospitalized patients

N. Marascio, E. Garofalo, F. Longhini, 2024, Journal of medical virology.

New Insights for Polyphenolic Compounds as Naturally Inspired Proteasome Inhibitors

S. Alcaro, F. A. Ambrosio, M. E. Gallo Cantafio, 2023, Pharmaceuticals.